|
|
|
Presented by Office of Genomics and Disease Prevention (OGDP), Centers for Disease Control and Prevention, Atlanta, GA and Foundation for Blood Research (FBR), Scarborough, ME
|
This short course was intended to inform participants about systematic approaches for evidence-based assessment of genetic tests. The content was developed to be useful to public health and health care professionals, policy makers, and others who are involved in the development, evaluation, utilization, regulation, and reimbursement of genetic tests for screening and prevention. Speakers addressed issues related to pre- and post-market evaluation of genetic tests, and included case studies and lessons learned from the CDC-sponsored ACCE Project and other review processes.The more than 60 professionals from the United States, Canada, the United Kingdom and the Netherlands who attended the short course were from state and Federal public health agencies, health care practice, health care provider organizations, industry, voluntary health organizations and advocacy groups, academic centers, and health technology assessment centers.
Centers for Disease Control & Prevention |
Foundation for Blood Research |
Muin Khoury, MD, PhD
Director, OGDP, CDC |
Linda A. Bradley, PhD
Geneticist, OGDP, CDC |
Melanie F. Myers, PhD
Public Health Geneticist, OGDP, CDC |
Paula W. Yoon, ScD, MPH
Epidemiologist, OGDP, CDC |
D. Joe Boone, PhD
Associate Director for Science,
Public Health Practice Program Office, CDC |
Peter A. Briss, MD, MPH
Chief, Community Guide Branch, CDC |
Scott Grosse, PhD
Health Economist, National Center for Birth Defects and Developmental Disabilities, CDC |
|
James E. Haddow, MD
Medical Director, FBR |
Glenn E. Palomaki, BS
Director, Biometry/Epidemiology, FBR |
Monica McClain, PhD
Asst. Director, Biometry/Epidemiology, FBR |
|
|
|
Page last updated: December 11, 2007
Content Source: CDC's Office of Public Health Genomics |
|